(Q35953515)

11 August 2017

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice (English)

1 reference

11 August 2017

0 references

0 references

ankylosing spondylitis

1 reference

3

Annelies Boonen

1 reference

11 August 2017

Bert Vander Cruyssen

1

1 reference

11 August 2017

Clio Ribbens

2

1 reference

11 August 2017

Herman Mielants

4

1 reference

11 August 2017

Kurt de Vlam

5

1 reference

11 August 2017

Jan Lenaerts

6

1 reference

11 August 2017

Serge Steinfeld

7

1 reference

11 August 2017

Filip Van den Bosch

8

1 reference

11 August 2017

Lode Dewulf

9

1 reference

11 August 2017

Nathan Vastesaeger

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

29 January 2007

1 reference

Annals of the Rheumatic Diseases

11 August 2017

1 reference

11 August 2017

66

1 reference

11 August 2017

8

1 reference

11 August 2017

1072-1077

1 reference

The burden of ankylosing spondylitis.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

ASAS/EULAR recommendations for the management of ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Sulfasalazine for ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Methotrexate for ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Cervical spine involvement in ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Conventional treatments for ankylosing spondylitis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

How to diagnose axial spondyloarthritis early

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Distribution of HLA-B alleles in Mexican Amerindian populations.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1954702

Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial

24 September 2018

1 reference

12 December 2020

The genetics of acute anterior uveitis

1 reference

12 December 2020

The HLA B27 antigen-spondylarthropathy association. Impact on clinical expression

1 reference

12 December 2020

A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis

1 reference

12 December 2020

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

1 reference

12 December 2020

Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2006.064543

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

17261531

1 reference